Pharmaceutical giant Teva announces new CEO

Teva Pharmaceutical Industries, the world's largest maker of generic drugs, said Thursday it had appointed a new chief executive to replace Jeremy Levin, who left abruptly in October.

The new CEO of the Israeli-based company is Erez Vigodman, 54, who is currently a member of Teva's board of directors.

Teva said in a statement he will take up his new position on February 11.

Vigodman currently also worked as head of the agrochemical group Makhteshim Agan Industries. He has sat on the Teva board since 2009.

Levin spent less than two years on the job.

Media reports have said he left because of disagreements with the chairman of the Teva board and major shareholder Philip Frost over the terms of a cost-cutting restructuring plan.

In October Teva announced it would trim its global workforce of 46,000 jobs by 10 percent by the end of 2014.

Vigodman is Israeli and holds degrees from Tel Aviv University and Harvard Business School.

add to favorites email to friend print save as pdf

Related Stories

CEO of drug maker Teva out ahead job cuts (Update)

Oct 30, 2013

Israeli drug manufacturer Teva Pharmaceuticals Ltd. announced Wednesday its CEO had resigned, following a public uproar over a contentious restructuring plan set to cut thousands of jobs worldwide.

Israel's Teva to pay $718 million in Israeli taxes

Nov 11, 2013

Israel's Teva Pharmaceuticals Industries Ltd. says it has reached an agreement with the country's tax authority to pay roughly $718 million to settle a series of claims against the drug maker.

Pfizer, Teva reach deal to allow generic Viagra

Dec 17, 2013

Pfizer says it reached a settlement with Teva Pharmaceuticals that allows the generic drugmaker to launch a copycat version of its popular erectile dysfunction drug Viagra in 2017.

Israeli generic drug giant Teva to buy Cephalon

May 02, 2011

Teva Pharmaceutical Industries, the world's largest generic drug maker, will buy US biopharma firm Cephalon in a $6.8 billion deal, the companies said in a joint statement Monday.

Recommended for you

Use new meningitis vaccines only for outbreaks

17 hours ago

(AP)—A U.S. panel on Thursday recommended that two new meningitis vaccines only be used for rare outbreaks, resisting tearful pleas to give it routinely to teens and college students.

New antibiotic avycaz approved

21 hours ago

(HealthDay)—The combination antibiotic Avycaz (ceftazidime-avibactam) has been approved by the U.S. Food and Drug Administration to treat adults with complicated infections of the intra-abdominal area or urinary tract, ...

Tagging drugs to fight counterfeit medicines

Feb 25, 2015

The U.S. and other countries are enacting rules to clamp down on the sales of fake pharmaceuticals, which pose a public health threat. But figuring out a system to track and authenticate legitimate drugs still faces significant ...

Watchdog group seeks FDA ban of antifungal tablets

Feb 24, 2015

(AP)—A consumer safety group is calling on the Food and Drug Administration to pull certain antifungal tablets off the market, saying there are safer medicines that do not carry risks of liver damage.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.